Monday, July 27, 2020 —
Belgian medical device company Indigo Diabetes announces today that it has raised 38 million euros in a Series B financing round. The money will be used to fund the onward development and the next research phase for its sensor which uses groundbreaking photonics technology. The invisible sensor chip aims to provide people with diabetes a substantially improved quality of life. At the same time, the sensor is designed to not only continuously measure glucose levels but also ketones in people with diabetes. The latter is a worldwide first and aims at enabling the faster detection of...
